Evidence map›Paper›PMID 27268201›Full record

ArticleBMC cancer2016

Factors influencing diagnosis delay of advanced breast cancer in Moroccan women.

A Maghous, F Rais, S Ahid, N Benhmidou, K Bellahamou, H Loughlimi, E Marnouche, S Elmajjaoui, H Elkacemi, T Kebdani and 1 more

Abstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

A MaghousDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco. magabdelhak@gmail.com.
F RaisDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
S AhidLaboratory of epidemiology and clinical research, School of medicine and pharmacy of Rabat, Mohammed V University in Rabat, Rabat, Morocco.
N BenhmidouDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
K BellahamouDepartment of Medical Oncology, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
H LoughlimiDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
E MarnoucheDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
S ElmajjaouiDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
H ElkacemiDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
T KebdaniDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
N BenjaafarDepartment of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelay in the diagnosis of breast cancer in symptomatic women of 3 months or more is associated with advanced stage and low survival. We conducted this study to learn more about the extent and reasons behind diagnosis delay of advanced breast cancer in Moroccan women.

methodsA group of patients with advanced breast cancer were interviewed at the National Institute of Oncology in Rabat during the period from February to December 2014. Diagnosis delay was devised into patient delay and system delay. Patient delay was defined as time from first symptoms until first medical consultation. System delay was defined as time from first presentation to a health care provider until definite diagnosis or treatment. Prospective information and clinical data were collected on a form during an interview with each patient and from medical records.

resultsIn all, 137 patients were interviewed. The mean age of women was 48.3 ± 10.4 years. The median of consultation time was 6[4,12] months and the median of diagnosis time was 1[1,3] months. Diagnosis delay was associated to a personal reason in 96 (70.1 %) patients and to a medical reason in 19 (13.9 %) patients. A number of factors predicted diagnosis delay: symptoms were not considered serious in 66 (55.9 %) patients; traditional therapy was applied in 15 (12.7 %) patients and fear of cancer diagnosis and/or treatment in 14 (11.9 %) patients. A use of traditional methods was significantly associated with rural residence and far away from basic health center (p = 0.000). Paradoxically, a family history of breast cancer was significantly higher in who report a fear of cancer diagnosis and/or treatment to diagnosis delay (p < 0.001). Also, a significantly higher risk of more than 6 months delay was found among rural women (P = 0.035) and women who live far away from specialized care center (P = 0.001).

conclusionsDiagnosis delay is very serious problem in Morocco. Diagnosis delay was associated with complex interactions between several factors and with advanced stages. There is a need for improving breast cancer information in our populations and training of general practitioners to reduce advanced breast cancer by promoting early detection.

Indexed as

AdultBreast NeoplasmsDelayed DiagnosisFemaleHumansMiddle AgedMoroccoPatient Acceptance of Health CareProspective StudiesRisk FactorsRural PopulationTime FactorsTime-to-TreatmentBreast cancerDiagnosis delayPatient delaySystem delay

Identifiers

PMID27268201
PMCPMC4897875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.